DEXTRAMER
LIVE

Serial Number

79081953

Owner

Immudex ApS

Attorney

Miriam D. Trudell

Filing Date

Dec 28, 2009

Add to watchlist:

No watchlists yet
View on USPTO

DEXTRAMER Trademark

Serial Number: 79081953 • Registration: 4040266

DEXTRAMER is a trademark filed by Immudex ApS on December 28, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Immudex ApS (8 trademarks)

Bredevej 2A

Entity Type: 99

Trademark Details

Filing Date

December 28, 2009

Registration Date

October 18, 2011

Published for Opposition

August 2, 2011

Goods & Services

Preparations for pharmaceutical purposes, pharmaceutical preparations for medical purposes, and chemical-pharmaceutical preparations, namely vaccines and for treating infections caused by CMV, LCMV, EBV, HIV, HPV, BK polyomavirus, HTLV, Hepatitis B, Hepatitis C, TB, Graft versus Host Disease, Diabetes, JC Polyomavirus, HHV-3 (Human Herpes Virus), Influenza, Murine Herpes, Malaria, Murine Polyomavirus, RSV, HPV, Herpes Simplex Virus II, Sendai Virus, M Bovis, Vesicular Stromatitis Virus, Vaccinia Virus, Toxoplasmosis, Trypanosomacruzi, SIV, and vaccines and treatments for cancer, diabetes, arthritis, schlerosis, Achlorhydra Autoimmune Active Chronic Hepatitis, Acute Disseminated Encephalomyelitis, Acute hemorrhagic leukoencephalitis, Addison's Disease, Agammaglobulinemia, Alopecia areata, Amyotrophic Lateral Sclerosis, Ankylosing Spondylitis, Anti-GBM/TBM Nephritis, Antiphospholipid syndrome, Antisynthetase syndrome, Arthritis, Atopic allergy, Atopic Dermatitis, Autoimmune Aplastic Anemia, Autoimmune cardiomyopathy, Autoimmune hemolytic anemia, Autoimmune hepatitis, Autoimmune inner ear disease, Autoimmune lymphoproliferative syndrome, Autoimmune peripheral neuropathy, Autoimmune pancreatitis, Autoimmune polyendocrine syndrome Types I, II, and III, Autoimmune progesterone dermatitis, Autoimmune thrombocytopenic purpura, Autoimmune uveitis, Balo disease/Balo concentric sclerosis, Bechets Syndrome, Berger's disease, Bickerstaff's encephalitis, Blau syndrome, Bullous Pemphigoid, Castleman's disease, Chagas disease, Chronic Fatigue Immune Dysfunction Syndrome, Chronic antiflammatory demyelinating polyneuropathy, Chronic recurrent multifocal ostomyelitis, Chronic lyme disease, Chronic obstructive pulmonary disease, Churg-Strauss syndrome, CicatricialPemphigoid, Coeliac disease, Cogan syndrome, old agglutinin disease, Complement component 2 deficiency, Cranial arteritis, CREST syndrome, Crohns Disease, Cushing's Syndrome, Cutaneous leukocytoclasticangiitis, Dego's disease, Dercum's disease, Dermatitis herpetiformis, Dermatomyositis, Diabetes mellitus type 1, Diffuse cutaneous systemic sclerosis, Dressler's syndrome, Discoid lupus erythematosus, Eczema, Endometriosis, Enthesitis-related arthritis, Eosinophilic fasciitis, Epidermolysisbullosaacquisita, Erythema nodosum, Essential mixed cryoglobulinemia, Evan's syndrome, Fibrodysplasiaossificans progressive, Fibromyalgia, Fibromyositis, Fibrosingaveolitis, Gastritis, Gastrointestinal pemphigoid, Giant cell arteritis, Glomerulonephritis, Goodpasture's syndrome, Graves' disease, Guillain-Barré syndrome (GBS), Hashimoto's encephalitis, Hashimoto's thyroiditis, Haemolyticanemia, Henoch-Schonleinpurpura, Herpes gestationis, Hidradenitissuppurativa, Hughes syndrome, Hypogammaglobulinemia, Idiopathic Inflammatory Demyelinating Diseases, Idiopathic pulmonary fibrosis, Idiopathic thrombocytopenic purpura, IgA nephropathy (Berger's disease), Inclusion body myositis, Inflammatory demyelinating , olyneuopathy, Interstitial cystitis, Irritable Bowel Syndrome (IBS), Juvenile idiopathic arthritis, Juvenile heumatoid arthritis, Kawasaki's Disease, Lambert-Eaton myasthenic syndrome, Leukocytoclasticvasculitis, Lichen planus, Lichen sclerosus, Linear IgA disease (LAD), Lou Gehrig's Disease (Amyotrophic lateral sclerosis), Lupoid hepatitis, Lupus erythematosus, Majeed syndrome, Ménière's disease, Microscopic, polyangiitis, Miller-Fisher syndrome, Mixed Connective Tissue Disease, Morphea, Mucha-Habermann disease, Muckle-Wells syndrome, Multiple Myeloma, Multiple Sclerosis, Myasthenia gravis, Myositis, Narcolepsy, Neuromyelitisoptica(Devic's Disease), Neuromyotonia, Occularcicatricialpemphigoid, Opsoclonus myoclonus syndrome, Ord's thyroiditis, Palindromic rheumatism, PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus), Paraneoplastic cerebellar degeneration, Paroxysmal nocturnal hemoglobinuria (PNH), Parry Romberg syndrome, Parsonnage-Turner syndrome, Pars planitis, Pemphigus, Pemphigus vulgaris, Pernicious anaemia, Perivenous encephalomyelitis, POEMS syndrome, Polyarteritisnodosa, Polymyalgia rheumatic, Polymyositis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Progressive inflammatory neuropathy, Psoriasis, Psoriatic Arthritis,Pyodermagangrenosum, Pure red cell aplasia, Rasmussen's encephalitis, Raynaud phenomenon, Relapsing polychondritis, Reiter's syndrome, Restless leg syndrome, Retroperitoneal fibrosis, Rheumatoid arthritis, Rheumatoid fever, Sarcoidosis, Schizophrenia, Schmidt syndrome, Schnitzler syndrome, Scleritis, Scleroderma, Sjögren's syndrome, Spondyloarthropathy, Sticky blood syndrome, Still's Disease, Stiff person syndrome, Subacute bacterial endocarditis (SBE), Susac's syndrome, Sweet syndrome, Sydenham Chorea, Sympathetic ophthalmia, Takayasu's arteritis, Temporal arteritis (giant cell arteritis), Tolosa-Hunt syndrome, Transverse Myelitis, Ulcerative Colitis, Undifferentiated connective tissue disease, Undifferentiated spondyloarthropathy, Vasculitis, Vitiligo, Wegener's granulomatosis, Wilson's syndrome, Wiskott-Aldrich syndrome, T-cell lymphoma, and T-cell infiltration of solid tumors and tissue; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes and for research, preparations for analysis for medical and research purposes, hereunder for each of the abovementioned preparations for development and analysis of vaccines and treatments targeting infections by CMV, LCMV, EBV, HIV, HPV, BK polyomavirus, HTLV, Hepatitis B, Hepatitis C, TB, Graft versus Host Disease, Diabetes, JC Polyomavirus, HHV-3 (Human Herpes Virus), Influenza, Murine Herpes, Malaria, Murine Polyomavirus, RSV, HPV, Herpes Simplex Virus II, Sendai Virus, M Bovis, Vesicular Stromatitis Virus, Vaccinia Virus, Toxoplasmosis, Trypanosomacruzi, SIV, and vaccines and treatments for cancer, diabetes, arthritis, schlerosis, Achlorhydra Autoimmune Active Chronic Hepatitis, Acute Disseminated Encephalomyelitis, Acute hemorrhagic leukoencephalitis, Addison's Disease, Agammaglobulinemia, Alopecia areata, Amyotrophic Lateral Sclerosis, Ankylosing Spondylitis, Anti-GBM/TBM Nephritis, Antiphospholipid syndrome, Antisynthetase syndrome, Arthritis, Atopic allergy, Atopic Dermatitis, Autoimmune Aplastic Anemia, Autoimmune cardiomyopathy, Autoimmune hemolytic anemia, Autoimmune hepatitis, Autoimmune inner ear disease, Autoimmune lymphoproliferative syndrome, Autoimmune peripheral neuropathy, Autoimmune pancreatitis, Autoimmune polyendocrine syndrome Types I, II, and III, Autoimmune progesterone dermatitis, Autoimmune thrombocytopenic purpura, Autoimmune uveitis, Balo disease/Balo concentric sclerosis, Bechets Syndrome, Berger's disease, Bickerstaff's encephalitis, Blau syndrome, Bullous Pemphigoid, Castleman's disease, Chagas disease, Chronic Fatigue Immune Dysfunction Syndrome, Chronic inflammatory demyelinating polyneuropathy, Chronic recurrent multifocal ostomyelitis, Chronic lyme disease, Chronic obstructive pulmonary disease, Churg-Strauss syndrome, CicatricialPemphigoid, Coeliac disease, Cogan syndrome, old agglutinin disease, Complement component 2 deficiency, Cranial arteritis, CREST syndrome, Crohns Disease, Cushing's Syndrome, Cutaneous leukocytoclasticangiitis, Dego's disease, Dercum's disease, Dermatitis herpetiformis, Dermatomyositis, Diabetes mellitus type 1, Diffuse cutaneous systemic sclerosis, Dressler's syndrome, Discoid lupus erythematosus, Eczema, Endometriosis, Enthesitis-related arthritis, Eosinophilic fasciitis, Epidermolysisbullosaacquisita, Erythema nodosum, Essential mixed cryoglobulinemia, Evan's syndrome, Fibrodysplasiaossificans progressive, Fibromyalgia, Fibromyositis, Fibrosingaveolitis, Gastritis, Gastrointestinal pemphigoid, Giant cell arteritis, Glomerulonephritis, Goodpasture's syndrome, Graves' disease, Guillain-Barré syndrome (GBS), Hashimoto's encephalitis, Hashimoto's thyroiditis, Haemolytic anemia,Henoch-Schonleinpurpura, Herpes gestationis, Hidradenitissuppurativa, Hughes syndrome, Hypogammaglobulinemia, Idiopathic Inflammatory Demyelinating Diseases, Idiopathic pulmonary fibrosis, Idiopathic thrombocytopenic purpura, IgA nephropathy (Berger's disease), Inclusion body myositis, Inflammatory demyelinating, olyneuopathy, Interstitial cystitis, Irritable Bowel Syndrome (IBS), Juvenile idiopathic arthritis, Juvenile heumatoid arthritis, Kawasaki's Disease, Lambert-Eaton myasthenic syndrome, Leukocytoclasticvasculitis, Lichen planus, Lichen sclerosus, Linear IgA disease (LAD), Lou Gehrig's Disease (Amyotrophiclateral sclerosis), Lupoid hepatitis, Lupus erythematosus, Majeed syndrome, Ménière's disease, Microscopic polyangiitis, Miller-Fisher syndrome, Mixed Connective Tissue Disease, Morphea, Mucha-Habermann disease, Muckle-Wells syndrome, Multiple Myeloma, Multiple Sclerosis, Myasthenia gravis, Myositis, Narcolepsy, Neuromyelitisoptica (Devic's Disease), Neuromyotonia, Occularcicatricialpemphigoid, Opsoclonus myoclonus syndrome, Ord's thyroiditis, Palindromic rheumatism, PANDAS (Pediatric autoimmune Neuropsychiatric Disorders Associated withStreptococcus), Paraneoplastic cerebellar degeneration, Paroxysmal nocturnal hemoglobinuria (PNH), Parry Romberg syndrome, Parsonnage-Turner syndrome, Pars planitis, Pemphigus, Pemphigus vulgaris, Pernicious anaemia, Perivenous encephalomyelitis, POEMS syndrome, Polyarteritisnodosa, Polymyalgia rheumatic, Polymyositis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Progressive inflammatory neuropathy, Psoriasis, Psoriatic Arthritis, Pyodermagangrenosum, Pure red cell aplasia, Rasmussen's encephalitis, Raynaud phenomenon, Relapsingpolychondritis, Reiter's syndrome, Restless leg syndrome, Retroperitoneal fibrosis, Rheumatoid arthritis, Rheumatoid fever, Sarcoidosis, Schizophrenia, Schmidt syndrome, Schnitzler syndrome, Scleritis, Scleroderma, Sjögren's syndrome, Spondyloarthropathy, Sticky blood syndrome, Still's Disease, Stiff person syndrome, Subacute bacterial endocarditis (SBE), Susac's syndrome, Sweet syndrome, Sydenham Chorea, Sympathetic ophthalmia, Takayasu's arteritis, Temporal arteritis (giant cell arteritis), Tolosa-Hunt syndrome, Transverse Myelitis, Ulcerative Colitis, Undifferentiated connective tissue disease, Undifferentiated spondyloarthropathy, Vasculitis, Vitiligo, Wegener's granulomatosis, Wilson's syndrome, Wiskott-Aldrich syndrome, T-cell lymphoma, and T-cell infiltration of solid tumors and tissue, and for use in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring

Scientific and technological services and research and design relating thereto in the field of vaccines, immunotherapy, and the measurement of immune responses; industrial analysis and research services in the field of vaccines, immunotherapy, and the measurement of immune responses; basic research and clinical research in the field of medicine and vaccine development

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 14, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 14, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 14, 2023 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 28, 2022 NA71
REGISTERED-SEC.71 ACCEPTED
May 28, 2022 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2022 APRE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 21, 2022 ADCH
TEAS SECTION 71 RECEIVED
Sep 28, 2021 ES71
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 12, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 12, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 12, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 12, 2021 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Oct 18, 2020 REM4
INTERNATIONAL REGISTRATION RENEWED
Jan 16, 2020 RNWL
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 25, 2019 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 31, 2017 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 9, 2017 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 9, 2017 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 8, 2017 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Mar 2, 2017 NREP
TEAS SECTION 71 RECEIVED
Feb 15, 2017 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 15, 2017 TCCA
NEW REPRESENTATIVE AT IB RECEIVED
Dec 22, 2016 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 18, 2016 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 15, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 30, 2012 FICS
FINAL DISPOSITION PROCESSED
May 30, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 18, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2011 R.PR
NOTIFICATION PROCESSED BY IB
Oct 2, 2011 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2011 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 13, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 13, 2011 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 29, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2011 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 8, 2011 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2011 CRFA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2011 REAP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2011 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2011 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2010 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 28, 2010 CHAN
ASSIGNED TO LIE
Dec 28, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2010 TROA
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 5, 2010 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 30, 2010 CRCV
REFUSAL PROCESSED BY IB
Jul 2, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 1, 2010 RFCS
REFUSAL PROCESSED BY MPU
Jun 1, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 30, 2010 RFCR
NON-FINAL ACTION WRITTEN
May 29, 2010 CNRT
APPLICATION FILING RECEIPT MAILED
May 26, 2010 MAFR
ASSIGNED TO EXAMINER
May 22, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 20, 2010 REPR